Desq Long
Sign in

Company

FENNEC PHARMACEUTICALS INC.

FENC · CIK 0001211583

SEC FORM 4
$32,799.95

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code M) of 15,545 shares at $2.11 per share.

Reporting Person Brughera Marco Maria · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001589776-26-000004 · filed 2026-09-16 · View filing →

SEC FORM 4
$159,958.05

FENNEC PHARMACEUTICALS INC. (FENC)

Sale of 15,545 shares at $10.29 per share.

Reporting Person Brughera Marco Maria · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001589776-26-000004 · filed 2026-09-16 · View filing →

SEC FORM 4
$121,100.00

FENNEC PHARMACEUTICALS INC. (FENC)

Sale of 10,000 shares at $12.11 per share.

Reporting Person Raykov Rosty · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001468316-26-000023 · filed 2026-09-01 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 2,778 shares at $0 per share.

Reporting Person Raykov Rosty · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001468316-26-000023 · filed 2026-09-01 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 1,703 shares at $0 per share.

Reporting Person Andrade Robert · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001468308-26-000030 · filed 2026-08-31 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 1,159 shares at $0 per share.

Reporting Person Hackman Jeffrey S. · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001926254-26-000014 · filed 2026-08-31 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 168 shares at $0 per share.

Reporting Person Evans Terry L · Officer Title Chief Commercial Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0002043317-26-000012 · filed 2026-08-31 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 168 shares at $0 per share.

Reporting Person Sayad Pierre Sargis · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0002043395-26-000012 · filed 2026-08-31 · View filing →

SEC FORM 4
$146,160.00

FENNEC PHARMACEUTICALS INC. (FENC)

Sale of 12,000 shares at $12.18 per share.

Reporting Person Sayad Pierre Sargis · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0002043395-26-000012 · filed 2026-08-31 · View filing →

SEC FORM 4
$0.00

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 156 shares at $0 per share.

Reporting Person Cioffi Christiana Marie · Officer Title Chief Strategy Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0002043411-26-000014 · filed 2026-08-31 · View filing →

SEC FORM 4
$111,832.80

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code M) of 21,928 shares at $5.10 per share.

Reporting Person Andrade Robert · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M

Traded Aug 28, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001468308-26-000028 · filed 2026-08-28 · View filing →

SEC FORM 4
$883,500.00

FENNEC PHARMACEUTICALS INC. (FENC)

Sale of 75,000 shares at $11.78 per share.

Reporting Person Andrade Robert · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001468308-26-000028 · filed 2026-08-28 · View filing →